IL145041A0 - Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives - Google Patents

Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives

Info

Publication number
IL145041A0
IL145041A0 IL14504100A IL14504100A IL145041A0 IL 145041 A0 IL145041 A0 IL 145041A0 IL 14504100 A IL14504100 A IL 14504100A IL 14504100 A IL14504100 A IL 14504100A IL 145041 A0 IL145041 A0 IL 145041A0
Authority
IL
Israel
Prior art keywords
derivatives
production
methods
pharmaceutical preparations
preparations containing
Prior art date
Application number
IL14504100A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL145041A0 publication Critical patent/IL145041A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14504100A 1999-03-25 2000-03-21 Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives IL145041A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903854A FR2791346B3 (fr) 1999-03-25 1999-03-25 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/000695 WO2000058292A1 (fr) 1999-03-25 2000-03-21 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
IL145041A0 true IL145041A0 (en) 2002-06-30

Family

ID=9543720

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14504100A IL145041A0 (en) 1999-03-25 2000-03-21 Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
IL145041A IL145041A (en) 1999-03-25 2001-08-21 Morpholine derivatives, methods for the production thereof and pharmaceutical preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145041A IL145041A (en) 1999-03-25 2001-08-21 Morpholine derivatives, methods for the production thereof and pharmaceutical preparations

Country Status (41)

Country Link
US (1) US6506750B1 (no)
EP (1) EP1165528B1 (no)
JP (1) JP3853155B2 (no)
KR (1) KR100696340B1 (no)
CN (1) CN100422160C (no)
AR (1) AR023139A1 (no)
AT (1) ATE275136T1 (no)
AU (1) AU756855B2 (no)
BG (1) BG64623B1 (no)
BR (1) BR0009281B1 (no)
CA (1) CA2366829C (no)
CO (1) CO5160340A1 (no)
CZ (1) CZ300911B6 (no)
DE (1) DE60013418T2 (no)
DK (1) DK1165528T3 (no)
EE (1) EE04525B1 (no)
ES (1) ES2226794T3 (no)
FR (1) FR2791346B3 (no)
HK (1) HK1042092B (no)
HR (1) HRP20010704B1 (no)
HU (1) HUP0201863A3 (no)
ID (1) ID29871A (no)
IL (2) IL145041A0 (no)
IS (1) IS2338B (no)
ME (2) ME00057B (no)
MX (1) MXPA01009643A (no)
NO (1) NO321576B1 (no)
NZ (1) NZ513674A (no)
PE (1) PE20001596A1 (no)
PL (1) PL205318B1 (no)
PT (1) PT1165528E (no)
RS (1) RS50085B (no)
RU (1) RU2222537C2 (no)
SI (1) SI1165528T1 (no)
SK (1) SK286977B6 (no)
TR (1) TR200102639T2 (no)
TW (1) TW534906B (no)
UA (1) UA73931C2 (no)
UY (1) UY26079A1 (no)
WO (1) WO2000058292A1 (no)
ZA (1) ZA200106981B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1353918B1 (en) * 2000-11-28 2005-01-12 Smithkline Beecham Plc Morpholine derivatives as antagonists of orexin receptors
FR2824828B1 (fr) * 2001-05-21 2005-05-20 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
AU2003300911A1 (en) * 2002-12-13 2004-07-09 Smithkline Beecham Corporation Heterocyclic compounds as ccr5 antagonists
JO2485B1 (en) * 2002-12-23 2009-01-20 شركة جانسين فارماسوتيكا ان. في 1-Piperidine-3-Yl-4-Piperidine-4-Yl-Piperazine derivatives substituted and used as quinine antagonists
BRPI0417950A (pt) * 2003-12-22 2007-04-17 Schering Corp composições farmacêuticas
FR2873373B1 (fr) 2004-07-23 2006-09-08 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
CN103142569B (zh) * 2013-02-27 2016-01-20 南京医科大学 2,6-二异丙基苯甲酸及其衍生物作为神经保护剂的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ3134U1 (cs) * 1995-01-10 1995-03-17 Pavel Ing. Janda Rotor universálního radiálního ventilátoru
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
US5780466A (en) * 1995-01-30 1998-07-14 Sanofi Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
RU2135494C1 (ru) * 1995-12-01 1999-08-27 Санкио Компани Лимитед Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
JP3192631B2 (ja) * 1997-05-28 2001-07-30 三共株式会社 飽和複素環化合物からなる医薬
BR9815348A (pt) * 1997-12-04 2000-10-17 Sankyo Co " composto, uso deste ou de um sal farmacologicamente aceitável, éster ou outro derivado do mesmo, medicamento, agentes preventivos ou terapêuticos para asma e/ou bronquite, para rinite, para doença alérgica, e para incontinência urinária, e, processos de prevenção ou tratamento de asma e/ou bronquite, de rinite, de doença alérgica, e de incontinência urinária. "

Also Published As

Publication number Publication date
HK1042092A1 (en) 2002-08-02
ID29871A (id) 2001-10-18
PE20001596A1 (es) 2001-04-01
JP3853155B2 (ja) 2006-12-06
IS6063A (is) 2001-08-24
CN100422160C (zh) 2008-10-01
MXPA01009643A (es) 2002-05-14
CN1353698A (zh) 2002-06-12
UA73931C2 (en) 2005-10-17
AR023139A1 (es) 2002-09-04
FR2791346A1 (fr) 2000-09-29
IL145041A (en) 2010-11-30
EP1165528B1 (fr) 2004-09-01
YU68201A (sh) 2004-03-12
HRP20010704B1 (en) 2005-04-30
ME00057B (me) 2010-10-10
FR2791346B3 (fr) 2001-04-27
HUP0201863A2 (hu) 2002-12-28
BG105923A (en) 2002-05-31
CZ300911B6 (cs) 2009-09-09
BR0009281A (pt) 2002-01-22
PL205318B1 (pl) 2010-04-30
DE60013418T2 (de) 2005-09-22
NO20014632L (no) 2001-11-26
NZ513674A (en) 2003-05-30
EE200100499A (et) 2002-12-16
RU2222537C2 (ru) 2004-01-27
CO5160340A1 (es) 2002-05-30
CA2366829C (fr) 2007-05-15
EP1165528A1 (fr) 2002-01-02
TW534906B (en) 2003-06-01
CZ20013365A3 (cs) 2002-01-16
RS50085B (sr) 2009-01-22
US6506750B1 (en) 2003-01-14
IS2338B (is) 2008-02-15
AU756855B2 (en) 2003-01-23
UY26079A1 (es) 2000-10-31
NO20014632D0 (no) 2001-09-24
ES2226794T3 (es) 2005-04-01
KR100696340B1 (ko) 2007-03-20
WO2000058292A1 (fr) 2000-10-05
HRP20010704A2 (en) 2002-08-31
TR200102639T2 (tr) 2002-02-21
AU3301600A (en) 2000-10-16
HUP0201863A3 (en) 2003-03-28
NO321576B1 (no) 2006-06-06
ATE275136T1 (de) 2004-09-15
CA2366829A1 (fr) 2000-10-05
JP2002540195A (ja) 2002-11-26
DK1165528T3 (da) 2005-01-10
PL351317A1 (en) 2003-04-07
BG64623B1 (bg) 2005-09-30
HK1042092B (zh) 2005-04-22
DE60013418D1 (de) 2004-10-07
KR20010108381A (ko) 2001-12-07
SI1165528T1 (en) 2005-02-28
ZA200106981B (en) 2002-10-24
SK13462001A3 (sk) 2002-05-09
SK286977B6 (sk) 2009-08-06
MEP12008A (en) 2010-06-10
EE04525B1 (et) 2005-08-15
PT1165528E (pt) 2005-01-31
BR0009281B1 (pt) 2011-05-17

Similar Documents

Publication Publication Date Title
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
MXPA01011039A (es) Derivados de 6-alquenilo, 6-alquinilo y 6-epoxi-epotilona, procesos para su produccion y su uso en preparaciones farmaceuticas..
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
AU2001284021A1 (en) Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
PL345863A1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HK1049655B (zh) 取代的降冰片基氨基衍生物，其製備和用途以及包含它們的藥物
IL145041A0 (en) Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
AU7904600A (en) Substituted piperazine derivatives, the production and use thereof as medicaments
HUP0200928A3 (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
HK1038927A1 (en) (1-Phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
AU7517800A (en) 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments
AU2942100A (en) Vitamin d derivatives and process for the preparation thereof
AU2003204342A1 (en) Piperazine derivatives and process for the preparation thereof
SI1194415T1 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation
SI1098874T1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
IL117302A (en) Cryptophycin derivatives, methods for the production thereof and pharmaceutical compositions containing the same
SI1165596T1 (en) 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them